NDC 55150-513 – Methotrexate
Methotrexate Sodium 250 mg/10mL · Injection, Solution · Intramuscular, Intrathecal, Intravenous, Subcutaneous
Product NDC55150-513
Product details
- Brand name
- Methotrexate
- Generic name
- Methotrexate
- Labeler
- Eugia US LLC
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intrathecal, Intravenous, Subcutaneous
- Marketing category
- ANDA · ANDA201529
- Marketed since
- September 11, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Folate Analog Metabolic Inhibitor
Active ingredients
- Methotrexate Sodium 250 mg/10mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55150-513-01 | 1 VIAL in 1 CARTON (55150-513-01) / 10 mL in 1 VIAL | Sep 11, 2024 |
Other Methotrexate products
- 50090-5457 Methotrexate Sodium 2.5 mg/1 · Tablet · A-S Medication Solutions
- 16729-486 Methotrexate Sodium 2.5 mg/1 · Tablet · Accord Healthcare Inc.
- 16729-277 Methotrexate 25 mg/mL · Injection · Accord Healthcare, Inc.
- 62332-711 Methotrexate Sodium 25 mg/mL · Injection, Solution · Alembic Pharmaceuticals Inc.
- 62332-712 Methotrexate Sodium 25 mg/mL · Injection, Solution · Alembic Pharmaceuticals Inc.
- 62332-730 Methotrexate Sodium 2.5 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 46708-730 Methotrexate Sodium 2.5 mg/1 · Tablet · Alembic Pharmaceuticals Limited
- 46708-712 Methotrexate Sodium 25 mg/mL · Injection, Solution · Alembic Pharmaceuticals Limited
- 46708-711 Methotrexate Sodium 25 mg/mL · Injection, Solution · Alembic Pharmaceuticals Limited
- 59651-182 Methotrexate Sodium 2.5 mg/1 · Tablet · Aurobindo Pharma Limited
- 42291-594 Methotrexate Sodium 2.5 mg/1 · Tablet · AvKARE
- 50268-554 Methotrexate 2.5 mg/1 · Tablet · AvPAK